Coegin Pharma
3.92 SEK
+3.16 %
Less than 1K followers
COEGIN
Nordic SME
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Quarter data
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Coegin Pharma
| Q3/24 | Q4/24 | 2024 | Q1/25 | Q2/25 | Q3/25 | Q4/25 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.1 | 0.1 | ||||||
| EBITDA | -4.8 | -6.4 | -20.3 | -4.9 | -3.2 | -3.3 | -6.1 | -17.4 |
| EBIT | -5.6 | -7.1 | -23.3 | -5.6 | -3.9 | -4.1 | -6.9 | -20.5 |
| EBIT-% | -8,575.0 % | -25,888.6 % | ||||||
| Profit before taxes | -5.7 | -7.0 | -23.8 | -5.6 | -3.9 | -4.1 | -6.9 | -20.5 |
| Net income | -5.7 | -7.0 | -23.8 | -5.6 | -3.9 | -4.1 | -6.9 | -20.5 |